KGI is a provider of investment banking and wealth management services for individuals and businesses... Read more
KGI is a provider of investment banking and wealth management services for individuals and businesses... Read more
CEO
Add
News
Apr 09, 2026
GlobeNewswire
Press Release: KGI Financial Service Group : Aureus Greenway Holdings Announces $50 Million Strategic Investment in Powerus from KCGI
Mar 13, 2026
Marketscreener
KGI Financial Service Group: KGI Financial Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
Mar 10, 2026
Mingtiandi
KGI Financial Service Group: Hong Kong's Arch Capital Sells Taiwan Warehouse to KGI Life for $201M
Nov 04, 2025
Marketscreener
KGI Financial Service Group: KGI Financial : CDIB Capital Innovation Advisors Expands Japan Presence, Signs Strategic MOU with GxPartners at Fukuoka Ramen Tech, and Launches CDIB Award to Support Startups
Sep 17, 2025
Marketscreener
KGI Financial Service Group: KGI Financial : CDIB Cross Border Innovation Fund Invests in Japanese AI Startup Visual Bank, Strengthening the Taiwan-Japan IP and Innovation Ecosystem
Jul 11, 2025
Marketscreener
KGI Financial Service Group: KGI Financial : Reports Profit After-tax of NT$3.613 Billion for June Cumulative Profit after-tax Reaches NT5.474 Billion for First Half, EPS NT0.29
Apr 22, 2025
EIN Presswire
Press Release: KGI Financial Service Group : KGI Financial Joins Global Earth Hour Initiative Angelo Koo Calls on Financial Industry to Strive for a Green future
Feb 04, 2025
EIN Presswire
Press Release: KGI Financial Service Group : KGI Financial and Angelo Koo Drive Growth for Enterprises Revitalization, Championing Taiwan's Sustainable Development
Jan 06, 2025
EIN Presswire
Press Release: KGI Financial Service Group : Financial Industry Spreads Christmas Cheer: Angelo Koo Champions Corporate Commitment to Supporting Taiwan's Communities
Jul 01, 2024
PR Newswire
Press Release: KGI Financial Service Group : Anbogen Therapeutics Announces Completion of A+ Round Financing to Advance ABT-301 Phase II Clinical Trial
